There are 2789 resources available
382O - Inhibition of WEE1 is effective in TP53 and RAS mutant metastatic colorectal cancer (mCRC): A randomised phase II trial (FOCUS4-C) comparing adavosertib (AZD1775) with active monitoring
Presenter: Jenny Seligmann
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 1
Resources:
Abstract
Slides
Webcast
386O - Exploratory biomarker analysis of DESTINY-CRC01, a phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd, DS-8201) in patients (pts) with HER2-expressing metastatic colorectal cancer (mCRC)
Presenter: Salvatore Siena
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 1
Resources:
Abstract
Slides
Webcast
1036O - Relatlimab (RELA) + nivolumab (NIVO) vs. NIVO in previously untreated metastatic or unresectable melanoma: Additional efficacy in RELATIVITY-047
Presenter: F. Stephen Hodi
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
1040O - Phase II trial of ipilimumab, nivolumab and tocilizumab for unresectable metastatic melanoma
Presenter: Jeffrey Weber
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
1037O - MASTERKEY-265: A phase III, randomized, placebo (Pbo)-controlled study of talimogene laherparepvec (T) plus pembrolizumab (P) for unresectable stage IIIB–IVM1c melanoma (MEL)
Presenter: Helen Gogas
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
1O - Harnessing innate immunity in cancer therapies: The example of natural killer cell engagers
Presenter: Eric Vivier
Session: Proffered Paper session - Basic science
Resources:
Abstract
Slides
Webcast
2O - Penpulimab, an IgG1 anti-PD-1 antibody with Fc-engineering to eliminate effector functions and with unique epitope and binding properties
Presenter: Baiyong Li
Session: Proffered Paper session - Basic science
Resources:
Abstract
Slides
Webcast
3O - Patient-derived micro-organospheres (MOS) recapitulate tumor microenvironment and heterogeneity for precision oncology
Presenter: Shengli Ding
Session: Proffered Paper session - Basic science
Resources:
Abstract
Slides
Webcast
1800O - Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
Presenter: Álvaro Quintanal-Villalonga
Session: Proffered Paper session - Basic science
Resources:
Abstract
Slides
Webcast
LBA20 - FOLFOXIRI plus bevacizumab (bev) plus atezolizumab (atezo) versus FOLFOXIRI plus bev as first-line treatment of unresectable metastatic colorectal cancer (mCRC) patients: Results of the phase II randomized AtezoTRIBE study by GONO
Presenter: Chiara Cremolini
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 1
Resources:
Abstract
Slides
Webcast